Keyword Index

A

  • Antifungal combination Evaluation of the combined efficacy of inhibitors of heat shock protein 90 and calcineurin with commonly used antifungals against Aspergillus, Rhizopus, and Fusarium isolates [Volume 11, Continuous, 2025]
  • Aspergillus Evaluation of the combined efficacy of inhibitors of heat shock protein 90 and calcineurin with commonly used antifungals against Aspergillus, Rhizopus, and Fusarium isolates [Volume 11, Continuous, 2025]

C

  • Candidemia 30-day mortality in invasive candidiasis and candidemia in a multidisciplinary hospital in Moscow, Russia [Volume 11, Continuous, 2025]
  • Clinical trials Addressing filamentous fungi-related onychomycosis in the era of antifungal resistance: assessment of Zataria multiflora nanostructured lipid carrier topical gel in a double-blinded clinical trial [Volume 11, Continuous, 2025]

D

  • Disseminated cryptococcosis Disseminated cryptococcosis in an HIV patient with hepatitis C as the associated risk factor [Volume 11, Continuous, 2025]

F

  • Filamentous fungi Addressing filamentous fungi-related onychomycosis in the era of antifungal resistance: assessment of Zataria multiflora nanostructured lipid carrier topical gel in a double-blinded clinical trial [Volume 11, Continuous, 2025]
  • Fusarium Evaluation of the combined efficacy of inhibitors of heat shock protein 90 and calcineurin with commonly used antifungals against Aspergillus, Rhizopus, and Fusarium isolates [Volume 11, Continuous, 2025]

H

  • HCV Disseminated cryptococcosis in an HIV patient with hepatitis C as the associated risk factor [Volume 11, Continuous, 2025]
  • Healthcare-associated infections 30-day mortality in invasive candidiasis and candidemia in a multidisciplinary hospital in Moscow, Russia [Volume 11, Continuous, 2025]
  • HIV Disseminated cryptococcosis in an HIV patient with hepatitis C as the associated risk factor [Volume 11, Continuous, 2025]
  • Hsp90/calcineurin inhibitors Evaluation of the combined efficacy of inhibitors of heat shock protein 90 and calcineurin with commonly used antifungals against Aspergillus, Rhizopus, and Fusarium isolates [Volume 11, Continuous, 2025]

I

  • Invasive candidiasis 30-day mortality in invasive candidiasis and candidemia in a multidisciplinary hospital in Moscow, Russia [Volume 11, Continuous, 2025]
  • IV Drug abuse Disseminated cryptococcosis in an HIV patient with hepatitis C as the associated risk factor [Volume 11, Continuous, 2025]

M

  • Mortality 30-day mortality in invasive candidiasis and candidemia in a multidisciplinary hospital in Moscow, Russia [Volume 11, Continuous, 2025]

N

  • Nanostructured lipid carrier Addressing filamentous fungi-related onychomycosis in the era of antifungal resistance: assessment of Zataria multiflora nanostructured lipid carrier topical gel in a double-blinded clinical trial [Volume 11, Continuous, 2025]

O

  • Onychomycosis Addressing filamentous fungi-related onychomycosis in the era of antifungal resistance: assessment of Zataria multiflora nanostructured lipid carrier topical gel in a double-blinded clinical trial [Volume 11, Continuous, 2025]

R

  • Rhizopus Evaluation of the combined efficacy of inhibitors of heat shock protein 90 and calcineurin with commonly used antifungals against Aspergillus, Rhizopus, and Fusarium isolates [Volume 11, Continuous, 2025]

Z

  • Zataria multiflora Addressing filamentous fungi-related onychomycosis in the era of antifungal resistance: assessment of Zataria multiflora nanostructured lipid carrier topical gel in a double-blinded clinical trial [Volume 11, Continuous, 2025]